Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones - PubMed (original) (raw)

Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones

Gabriel Cabot et al. Antimicrob Agents Chemother. 2012 Dec.

Abstract

Recent reports have revealed the existence of widespread extensively drug-resistant (XDR) P. aeruginosa high-risk clones in health care settings, but there is still scarce information on their specific chromosomal (mutational) and acquired resistance mechanisms. Up to 20 (10.5%) of 190 bloodstream isolates collected from 10 Spanish hospitals met the XDR criteria. A representative number (15 per group) of isolates classified as multidrug-resistant (MDR) (22.6%), resistant to 1 to 2 classes (moderately resistant [modR]) (23.7%), or susceptible to all antibiotics (multiS) (43.2%) were investigated in parallel. Multilocus sequence typing (MLST) analysis revealed that all XDR isolates belonged to sequence type 175 (ST175) (n = 19) or ST111 (n = 1), both recognized as international high-risk clones. Clonal diversity was higher among the 15 MDR isolates (4 ST175, 2 ST111, and 8 additional STs) and especially high among the 15 modR (13 different STs) and multiS (14 STs) isolates. The XDR/MDR pattern in ST111 isolates correlated with the production of VIM-2, but none of the ST175 isolates produced acquired β-lactamases. In contrast, the analysis of resistance markers in 12 representative isolates (from 7 hospitals) of ST175 revealed that the XDR pattern was driven by the combination of AmpC hyperproduction, OprD inactivation (Q142X), 3 mutations conferring high-level fluoroquinolone resistance (GyrA T83I and D87N and ParC S87W), a G195E mutation in MexZ (involved in MexXY-OprM overexpression), and the production of a class 1 integron harboring the aadB gene (gentamicin and tobramycin resistance). Of particular interest, in nearly all the ST175 isolates, AmpC hyperproduction was driven by a novel AmpR-activating mutation (G154R), as demonstrated by complementation studies using an ampR mutant of PAO1. This work is the first to describe the specific resistance markers of widespread P. aeruginosa XDR high-risk clones producing invasive infections.

PubMed Disclaimer

Figures

Fig 1

Fig 1

Distribution of STs among the XDR, MDR, modR, and multiS isolates studied. The number of isolates of each ST is shown in parentheses.

Fig 2

Fig 2

Results for double-disk (imipenem-ceftazidime) AmpC induction test in wild-type PAO1, the ampR knockout mutant PAΔR, and PAΔR complemented with wild-type ampR (pUCPARWT) or with the G154R mutant (pUCPARG154R).

Similar articles

Cited by

References

    1. Bagge N, et al. 2002. Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD. Antimicrob. Agents Chemother. 46:3406–3411 - PMC - PubMed
    1. Balasubramanian D, et al. 2011. Co-regulation of b-lactam resistance, alginate production and quorum sensing in Pseudomonas aeruginosa. J. Med. Microbiol. 60:147–156 - PMC - PubMed
    1. Balasubramanian D, et al. 2012. The regulatory Repertoire of Pseudomonas aeruginosa AmpC β-lactamase regulator AmpR includes virulence genes. PLoS One 7:e34067 doi:<10.1371/journal.pone.0034067> - DOI - PMC - PubMed
    1. Balcewich MD, et al. 2010. Crystal structure of the AmpR effector binding domain provides insight into the molecular regulation of inducible AmpC beta-lactamase. J. Mol. Biol. 400:998–1010 - PubMed
    1. Baquero F. 2004. From pieces to patterns: evolutionary engineering in bacterial pathogens. Nat. Rev. Microbiol. 2:510–518 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources